As more covalent candidates entered the clinic and more companies turned to covalency to overcome efficacy and safety challenges, confidence in covalency is growing. Amongst this buzz, the 3^rd Covalent Drug Discovery & Development Summit returned to Boston with a completely refreshed speaker faculty to deliver the most up-to-date insights on everything covalent.

Covering end-to-end challenges, from covalent library generation and hit identification, to modelling PK/PD and exploring novel covalent modalities, this meeting was dedicated to equipping covalent experts like yourself with the tools, lessons and data to discover the next wave of clinically successful covalent therapies.